Global High-flow Nasal Cannula Market: Snapshot
Some of the prominent participants in the global high flow nasal cannula market are Fisher & Paykel Healthcare Limited, ResMed, Inc., Teijin Pharma Limited, Becton, Dickinson and Company, MEK-ICS CO., LTD., Teleflex Incorporated, Smiths Medical, Vapotherm, Inc., Flexicare Medical Limited, Salter Labs, Hamilton Medical, TNI medical AG, and Great Group Medical Co., Ltd. Of them, Fisher & Paykel Healthcare Limited emerged as the market leader in 2016.
Numerous factors are driving growth in the global high flow nasal cannula market. At the forefront is the ever-increasing number of respiratory disorders. Besides, soaring popularity and uptake of heated humidified high-flow nasal cannulas and increasing investments in research and development programs by companies to come up with better products leveraging more sophisticated technologies is also positively impacting sales. A noticeable trend in the market is the focus of local players on cost-effective products.
A study by Transparency Market Research, predicts the global nasal cannula market to rise at a 11.8% CAGR from 2017 to 2025 to become worth US$9.08 bn by 2025 from US$3.42 bn 2016.
Continued Innovations Propel Active Humidifiers Component to Fore
The global high-flow nasal cannula market can be segmented based on different parameters. Depending upon component, for example, the market can be divided into air/oxygen blender, nasal cannulas, active humidifier, single heated tube, and other consumables. Of them, the segment of active humidifier held maximum share in the market in 2016 and it was trailed by the segment of air/oxygen blender. In the near future too, active humidifiers will continue to retain their dominant market share on the back of continued innovations in humidifiers by manufacturers and health care solution providers in order to up their efficacy.
Application-wise, the key segments of the global high-flow nasal cannula market are acute respiratory failure, acute heart failure, chronic obstructive pulmonary disease (COPD), carbon monoxide toxicity, sleep apnea, bronchiectasis, etc. The acute respiratory failure segment, of them, held a major share in the market in 2016. It was followed by chronic obstructive pulmonary disease segment. This is because of the rampant acute respiratory failure in newborns, children, and adults.
Ambulatory care centers, long-term care centers, hospitals, etc. are some of the main end-users in the global high-flow nasal cannula market.
Helpful Healthcare and Reimbursement Policies Make North America Market Dominant
From a geographical perspective, currently North America holds a dominant share in the global high-flow nasal cannula market mainly because of the substantial increase in the number of people afflicted with respiratory diseases. Affordability, awareness and helpful healthcare and reimbursement policies are also benefitting the market majorly. By registering an 11.2% CAGR between 2017 and 2025, the market in the region is predicted to grow its dominant share further. The TMR report expects the market to rake in a revenue of US$3.91 bn by 2025.
Europe follows North America in the second position in the global high-flow nasal cannula market. The region is projected to rise at a CAGR of 11.7% from 2017 to 2025 to pull in a revenue of US$2.08 by 2025. In terms of growth rate, on the other hand, Asia Pacific is expected to surpass all other regions by clocking a CAGR of 12.9% in the forecast period. The high-flow cannula market in Asia Pacific is expected to rise on the back of favorable demographics, improved health care policies, and the fast-paced economic growth in the region.
Considerable Technological Progress Made by Market Players to Drive High-flow Nasal Cannula Market
The global high-flow nasal cannula market is expected to be driven by the technological progress made by the prominent market players. In addition to that, clinical trials for the purpose of evaluation of new areas of application are likely to open up new avenues of growth for the global high-flow nasal cannula market in the years to come. Addiction of smoking, increasing level of pollution, and deterioration in the quality of air all over the world is anticipated to work in favor of the market in the years to come.
There has been augmented prevalence of different respiratory disorders across the globe. Acute respiratory failures are foreseen to find extensive use of high-flow oxygen therapy utilizing high-flow nasal cannula, thereby bolstering growth of the market. Covid-19 is a disease caused by SARS-CoV-2 virus affecting upper respiratory tract and leading to its infection. Use of high-flow nasal cannula is expected to provide relief from the complications faced by Covid-19 patients. As such, outbreak of Covid-19 is anticipated to widen scope of growth of the global high-flow nasal cannula market in the forthcoming years.
High Prevalence of Respiratory Diseases, COPD and Asthma, to Propel Market Growth
There has been increasing incidences of chronic obstructive pulmonary disease (COPD) and asthma across the globe. In the last few years, there has been exponential rise in the number of smokers along with the level of pollutants in air, especially in the developing parts of the world. Asthma refers to a medical condition in which airways become narrow and swollen. In this condition, airways also produce mucus and leads to repeated attacks of breathlessness, coughing, and wheezing, which varies in frequency and severity from person to person. In accordance with WHO (World Health Organization), Asthma is one of the major non-communicable diseases worldwide. WHO estimates that there are around 339 million asthma patients in the world. Such wide prevalence of the disease is anticipated to foster development of the global high-flow nasal cannula market in the forthcoming years.
The Global High-flow nasal cannulas Market is segmented as given below:
|
by Component |
|
|
by Application |
|
|
by End User |
|
|
by Geography |
|
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global High-flow Nasal Cannula Market
4. Market Overview
4.1. Introduction
4.1.1. Component Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Key Market Indicators
4.4. Market Dynamics
4.4.1. Drivers
4.4.1.1. Rising Incidence of Respiratory Disorders
4.4.1.2. Technology Advances in the High-flow Nasal Cannula Systems
4.4.1.3. Growing Applications of the High-flow Nasal Cannula Therapy
4.4.2. Restraints
4.4.2.1. Limitations of the High-flow Nasal Cannula Therapy
4.4.3. Opportunity
4.4.3.1. Large untapped patient population for oxygen therapy
4.4.3.2. Increasing focus of health organizations around the world towards home healthcare
4.5. Global High-flow Nasal Cannula Market Analysis and Forecasts, 2015–2025
4.5.1. Market Revenue Projections (US$ Mn)
4.6. Porter’s Five Force Analysis
4.7. Value Chain Analysis
4.8. Market Outlook
4.9. Brand Share Analysis, by Top Brands, 2016
4.10. Reimbursement Scenario, By Key Countries (U.S., Germany, Italy, Denmark, Australia & New Zealand, Korea)
5. Global High-flow Nasal Cannula Market Analysis and Forecasts, By Component
5.1. Introduction & Definition
5.2. Key Findings / Developments
5.3. Key Trends
5.4. Market Value Forecast By Component, 2015–2025
5.4.1. Air/Oxygen Blender
5.4.2. Active Humidifier
5.4.3. Single Heated Tube
5.4.4. Nasal Cannula
5.4.5. Other Consumables
5.6. Market Attractiveness By Component
6. Global High-flow Nasal Cannula Market Analysis and Forecasts, By Application
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Key Trends
6.4. Market Value Forecast By Application, 2015–2025
6.4.1. Acute Respiratory Failure
6.4.2. chronic obstructive pulmonary disease (COPD)
6.4.3. Acute Heart Failure
6.4.4. Carbon Monoxide Toxicity
6.4.5. Sleep Apnea
6.4.6. Bronchiectasis
6.4.7. Other Applications
6.5. Market Attractiveness By Application
7. Global High-flow Nasal Cannula Market Analysis and Forecasts, By End User
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Key Trends
7.4. Market Value Forecast By End User, 2015–2025
7.4.1. Hospitals
7.4.2. Long-term Care Centers
7.4.3. Ambulatory Care Centers
7.4.4. Other End-users
7.5. Market Attractiveness By End User
8. Global High-flow Nasal Cannula Market Analysis and Forecasts, By Region
8.1. Key Findings
8.2. Policies and Regulations
8.3. Market Value Forecast By Region
8.3.1. North America
8.3.2. Europe
8.3.3. Asia Pacific
8.3.4. Latin America
8.3.5. Middle East & Africa
8.4. Market Attractiveness By Region
9. North America High-flow Nasal Cannula Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.1.2. Policies and Regulations
9.1.3. Key Trends
9.2. Market Value Forecast By Component, 2015–2025
9.2.1. Air/Oxygen Blender
9.2.2. Active Humidifier
9.2.3. Single Heated Tube
9.2.4. Nasal Cannula
9.2.5. Other Consumables
9.3. Market Value Forecast By Application, 2015–2025
9.3.1. Acute Respiratory Failure
9.3.2. chronic obstructive pulmonary disease (COPD)
9.3.3. Acute Heart Failure
9.3.4. Carbon Monoxide Toxicity
9.3.5. Sleep Apnea
9.3.6. Bronchiectasis
9.3.7. Other Applications
9.4. Market Value Forecast By End User, 2015–2025
9.4.1. Hospitals
9.4.2. Long-term Care Centers
9.4.3. Ambulatory Care Centers
9.4.4. Other End-users
9.5. Market Value Forecast By Country, 2015–2025
9.5.1. U.S.
9.5.2. Canada
9.6. Market Attractiveness Analysis
9.6.1. By Component
9.6.2. By Application
9.6.3. By End User
9.6.4. By Country
10. Europe High-flow Nasal Cannula Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.1.2. Policies and Regulations
10.1.3. Key Trends
10.2. Market Value Forecast By Component, 2015–2025
10.2.1. Air/Oxygen Blender
10.2.2. Active Humidifier
10.2.3. Single Heated Tube
10.2.4. Nasal Cannula
10.2.5. Other Consumables
10.3. Market Value Forecast By Application, 2015–2025
10.3.1. Acute Respiratory Failure
10.3.2. chronic obstructive pulmonary disease (COPD)
10.3.3. Acute Heart Failure
10.3.4. Carbon Monoxide Toxicity
10.3.5. Sleep Apnea
10.3.6. Bronchiectasis
10.3.7. Other Applications
10.4. Market Value Forecast By End User, 2015–2025
10.4.1. Hospitals
10.4.2. Long-term Care Centers
10.4.3. Ambulatory Care Centers
10.4.4. Other End-users
10.5. Market Value Forecast By Country, 2015–2025
10.5.1. Germany
10.5.2. U.K.
10.5.3. France
10.5.4. Italy
10.5.5. Spain
10.5.6. Russia
10.5.7. Rest of Europe
10.6. Market Attractiveness Analysis
10.6.1. By Component
10.6.2. By Application
10.6.3. By End User
10.6.4. By Country
11. Asia Pacific High-flow Nasal Cannula Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.1.2. Policies and Regulations
11.1.3. Key Trends
11.2. Market Value Forecast By Component, 2015–2025
11.2.1. Air/Oxygen Blender
11.2.2. Active Humidifier
11.2.3. Single Heated Tube
11.2.4. Nasal Cannula
11.2.5. Other Consumables
11.3. Market Value Forecast By Application, 2015–2025
11.3.1. Acute Respiratory Failure
11.3.2. chronic obstructive pulmonary disease (COPD)
11.3.3. Acute Heart Failure
11.3.4. Carbon Monoxide Toxicity
11.3.5. Sleep Apnea
11.3.6. Bronchiectasis
11.3.7. Other Applications
11.4. Market Value Forecast By End User, 2015–2025
11.4.1. Hospitals
11.4.2. Long-term Care Centers
11.4.3. Ambulatory Care Centers
11.4.4. Other End-users
11.5. Market Value Forecast By Country, 2015–2025
11.5.1. China
11.5.2. India
11.5.3. Japan
11.5.4. Australia & New Zealand
11.5.5. Rest of Asia Pacific
11.6. Market Attractiveness Analysis
11.6.1. By Component
11.6.2. By Application
11.6.3. By End User
11.6.4. By Country
12. Latin America High-flow Nasal Cannula Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.1.2. Price Trend Analysis
12.1.3. Key Trends
12.2. Market Value Forecast By Component, 2015–2025
12.2.1. Air/Oxygen Blender
12.2.2. Active Humidifier
12.2.3. Single Heated Tube
12.2.4. Nasal Cannula
12.2.5. Other Consumables
12.3. Market Value Forecast By Application, 2015–2025
12.3.1. Acute Respiratory Failure
12.3.2. chronic obstructive pulmonary disease (COPD)
12.3.3. Acute Heart Failure
12.3.4. Carbon Monoxide Toxicity
12.3.5. Sleep Apnea
12.3.6. Bronchiectasis
12.3.7. Other Applications
12.4. Market Value Forecast By End User, 2015–2025
12.4.1. Hospitals
12.4.2. Long-term Care Centers
12.4.3. Ambulatory Care Centers
12.4.4. Other End-users
12.5. Market Value Forecast By Country, 2015–2025
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Market Attractiveness Analysis
12.6.1. By Component
12.6.2. By Application
12.6.3. By End User
12.6.4. By Country
13. Middle East & Africa High-flow Nasal Cannula Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.1.2. Policies and Regulations
13.1.3. Key Trends
13.2. Market Value Forecast By Component, 2015–2025
13.2.1. Air/Oxygen Blender
13.2.2. Active Humidifier
13.2.3. Single Heated Tube
13.2.4. Nasal Cannula
13.2.5. Other Consumables
13.3. Market Value Forecast By Application, 2015–2025
13.3.1. Acute Respiratory Failure
13.3.2. chronic obstructive pulmonary disease (COPD)
13.3.3. Acute Heart Failure
13.3.4. Carbon Monoxide Toxicity
13.3.5. Sleep Apnea
13.3.6. Bronchiectasis
13.3.7. Other Applications
13.4. Market Value Forecast By End User, 2015–2025
13.4.1. Hospitals
13.4.2. Long-term Care Centers
13.4.3. Ambulatory Care Centers
13.4.4. Other End-users
13.5. Market Value Forecast By Country, 2015–2025
13.5.1. GCC Countries
13.5.2. South Africa
13.5.3. Rest of Middle East & Africa
13.6. Market Attractiveness Analysis
13.6.1. By Component
13.6.2. By Application
13.6.3. By End User
13.6.4. By Country
14. Competition Landscape
14.1. Market Player – Competition Matrix (By Tier and Size of companies)
14.2. Market Share Analysis By Company (2016)
14.3. Company Profiles
14.3.1. Flexicare Medical Limited
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Financial Overview
14.3.1.3. Product Portfolio
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. Teijin Pharma Limited
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Financial Overview
14.3.2.3. Product Portfolio
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. Vapotherm
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Financial Overview
14.3.3.3. Product Portfolio
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. Salter Labs
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Financial Overview
14.3.4.3. Product Portfolio
14.3.4.4. SWOT Analysis
14.3.4.5. Strategic Overview
14.3.5. Teleflex Incorporated
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Financial Overview
14.3.5.3. Product Portfolio
14.3.5.4. SWOT Analysis
14.3.5.5. Strategic Overview
14.3.6. Fisher & Paykel Healthcare Limited
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Financial Overview
14.3.6.3. Product Portfolio
14.3.6.4. SWOT Analysis
14.3.6.5. Strategic Overview
14.3.7. ResMed, Inc.
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Financial Overview
14.3.7.3. Product Portfolio
14.3.7.4. SWOT Analysis
14.3.7.5. Strategic Overview
14.3.8. Smiths Medical
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Financial Overview
14.3.8.3. Product Portfolio
14.3.8.4. SWOT Analysis
14.3.8.5. Strategic Overview
14.3.9. Hamilton Medical
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Financial Overview
14.3.9.3. Product Portfolio
14.3.9.4. SWOT Analysis
14.3.9.5. Strategic Overview
14.3.10. TNI Medical AG
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Financial Overview
14.3.10.3. Product Portfolio
14.3.10.4. SWOT Analysis
14.3.10.5. Strategic Overview
14.3.11. Great Group Medical Co., Ltd.
14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.11.2. Financial Overview
14.3.11.3. Product Portfolio
14.3.11.4. SWOT Analysis
14.3.11.5. Strategic Overview
14.3.12. MEK-ICS CO., Ltd.
14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.12.2. Financial Overview
14.3.12.3. Product Portfolio
14.3.12.4. SWOT Analysis
14.3.12.5. Strategic Overview
14.3.13. Becton, Dickinson and Company
14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.13.2. Financial Overview
14.3.13.3. Product Portfolio
14.3.13.4. SWOT Analysis
14.3.13.5. Strategic Overview
14.3.14. Others
15. Key Take Aways
List of Tables
Table 01: Global High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast, by Component, 2015–2025
Table 02: Global High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast, by Application, 2015–2025
Table 03: Global High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast, by End-user, 2015–2025
Table 04: Global High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast, by Region, 2015–2025
Table 05: North America High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast, by Country, 2015–2025
Table 06: North America High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast, by Component, 2015–2025
Table 07: North America High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast, by Application, 2015–2025
Table 08: North America High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast, by End-user, 2015–2025
Table 09: Europe High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast, by Country, 2015–2025
Table 10: Europe High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast, by Component, 2015–2025
Table 11: Europe High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast, by Application, 2015–2025
Table 12: Europe High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast, by End-user, 2015–2025
Table 13: Asia Pacific High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast, by Country, 2015–2025
Table 14: Asia Pacific High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast, by Component, 2015–2025
Table 15: Asia Pacific High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast, by Application, 2015–2025
Table 16: Asia Pacific High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast, by End-user, 2015–2025
Table 17: Latin America High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast, by Country, 2015–2025
Table 18: Latin America High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast, by Component, 2015–2025
Table 19: Latin America High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast, by Application, 2015–2025
Table 20: Latin America High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast, by End-user, 2015–2025
Table 21: Middle East & Africa High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast, by Country, 2015–2025
Table 22: Middle East & Africa High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast, by Component, 2015–2025
Table 23: Middle East & Africa High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast, by Application, 2015–2025
Table 24: Middle East & Africa High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast, by End-user, 2015–2025
List of Figures
Figure 01: Global High-flow Nasal Cannula Market Snapshot
Figure 02: Global High-flow Nasal Cannula, Market Size (US$ Mn) Forecast, 2015–2025
Figure 03: Global High-flow Nasal Cannula Market Value Share, by Application (2016)
Figure 04: Global High-flow Nasal Cannula Market Value Share, by Component (2016)
Figure 05: Global High-flow Nasal Cannula Market Value Share, by End User (2016)
Figure 06: Global High-flow Nasal Cannula Market Value Share, by Region (2016)
Figure 07: Global High-flow Nasal Cannula Market Value Share, by Component, 2017 and 2025
Figure 08: Global High-flow Nasal Cannula Market Attractiveness, by Component, 2017–2025
Figure 09: Global High-flow Nasal Cannula Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Air/Oxygen Blender, 2015–2025
Figure 10: Global High-flow Nasal Cannula Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Active Humidifier, 2015–2025
Figure 11: Global High-flow Nasal Cannula Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Single Heated Tube, 2015–2025
Figure 12: Global High-flow Nasal Cannula Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Nasal Cannula, 2015–2025
Figure 13: Global High-flow Nasal Cannula Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Other Consumables, 2015–2025
Figure 14: Global High-flow Nasal Cannula Market Value Share, by Application, 2017 and 2025
Figure 15: Global High-flow Nasal Cannula Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Acute Respiratory Failure Application, 2015–2025
Figure 16: Global High-flow Nasal Cannula Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Chronic Obstructive Pulmonary Disease Application, 2015–2025
Figure 17: Global High-flow Nasal Cannula Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Acute Heart Failure Application, 2015–2025
Figure 18: Global High-flow Nasal Cannula Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Carbon Monoxide Toxicity Application, 2015–2025
Figure 19: Global High-flow Nasal Cannula Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Sleep Apnea Application, 2015–2025
Figure 20: Global High-flow Nasal Cannula Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Bronchiectasis Application, 2015–2025
Figure 21: Global High-flow Nasal Cannula Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Other Applications, 2015–2025
Figure 22: Global High-flow Nasal Cannula Market Attractiveness, by Application, 2017-2025
Figure 23: Global High-flow Nasal Cannula Market Value Share, by End-user, 2017 and 2025
Figure 24: Global High-flow Nasal Cannula Market Attractiveness, by End-user, 2017–2025
Figure 25: Global High-flow Nasal Cannula Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Hospitals, 2015–2025
Figure 26: Global High-flow Nasal Cannula Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Long-term Care Centers, 2015–2025
Figure 27: Global High-flow Nasal Cannula Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Ambulatory Care Centers, 2015–2025
Figure 28: Global High-flow Nasal Cannula Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Other End Users, 2015–2025
Figure 29: Global High-flow Nasal Cannula Market Value Share, by Region, 2017 and 2025
Figure 30: Global High-flow Nasal Cannula Market Attractiveness, by Region, 2017–2025
Figure 31: North America High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025
Figure 32: North America High-flow Nasal Cannula Market Value Share, by Country, 2017 and 2025
Figure 33: North America High-flow Nasal Cannula Market Attractiveness, by Country, 2017–2025
Figure 34: North America High-flow Nasal Cannula Market Value Share, by Component, 2017 and 2025
Figure 35: North America High-flow Nasal Cannula Market Attractiveness, by Component, 2017–2025
Figure 36: North America High-flow Nasal Cannula Market Value Share, by Application, 2017 and 2025
Figure 37: North America High-flow Nasal Cannula Market Attractiveness, by Application, 2017–2025
Figure 38: North America High-flow Nasal Cannula Market Value Share, by End-user, 2017 and 2025
Figure 39: North America High-flow Nasal Cannula Market Attractiveness, by End-user, 2017–2025
Figure 40: Europe High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
Figure 41: Europe High-flow Nasal Cannula Market Value Share, by Country, 2017 and 2025
Figure 42: Europe High-flow Nasal Cannula Market Attractiveness, by Country, 2017–2025
Figure 43: Europe High-flow Nasal Cannula Market Value Share, by Component, 2017 and 2025
Figure 44: Europe High-flow Nasal Cannula Market Attractiveness, by Component, 2017–2025
Figure 45: Europe High-flow Nasal Cannula Market Value Share, by Application, 2017 and 2025
Figure 46: Europe High-flow Nasal Cannula Market Attractiveness, by Application, 2017–2025
Figure 47: Europe High-flow Nasal Cannula Market Value Share, by End-user, 2017 and 2025
Figure 48: Europe High-flow Nasal Cannula Market Attractiveness, by End-user, 2017–2025
Figure 49: Asia Pacific High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), 2015–2025
Figure 50: Asia Pacific High-flow Nasal Cannula Market Value Share, by Country, 2017 and 2025
Figure 51: Asia Pacific High-flow Nasal Cannula Market Attractiveness, by Country, 2017–2025
Figure 52: Asia Pacific High-flow Nasal Cannula Market Value Share, by Component, 2017 and 2025
Figure 53: Asia Pacific High-flow Nasal Cannula Market Attractiveness, by Component, 2017–2025
Figure 54: Asia Pacific High-flow Nasal Cannula Market Value Share, by Application, 2017 and 2025
Figure 55: Asia Pacific High-flow Nasal Cannula Market Attractiveness, by Application, 2017–2025
Figure 56: Asia Pacific High-flow Nasal Cannula Market Value Share, by End-user, 2017 and 2025
Figure 57: Asia Pacific High-flow Nasal Cannula Market Attractiveness, by End-user, 2017–2025
Figure 58: Latin America High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), 2015–2025
Figure 59: Latin America High-flow Nasal Cannula Market Value Share, by Country, 2017 and 2025
Figure 60: Latin America High-flow Nasal Cannula Market Attractiveness, by Country, 2017–2025
Figure 61: Latin America High-flow Nasal Cannula Market Value Share, by Component, 2017 and 2025
Figure 62: Latin America High-flow Nasal Cannula Market Attractiveness, by Component, 2017–2025
Figure 63: Latin America High-flow Nasal Cannula Market Value Share, by Application, 2017 and 2025
Figure 64: Latin America High-flow Nasal Cannula Market Attractiveness, by Application, 2017–2025
Figure 65: Latin America High-flow Nasal Cannula Market Value Share, by End-user, 2017 and 2025
Figure 66: Latin America High-flow Nasal Cannula Market Attractiveness, by End-user, 2017–2025
Figure 67: Middle East & Africa High-flow Nasal Cannula Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
Figure 68: Middle East & Africa High-flow Nasal Cannula Market Value Share, by Country, 2017 and 2025
Figure 69: Middle East & Africa High-flow Nasal Cannula Market Attractiveness, by Country, 2017–2025
Figure 70: Middle East & Africa High-flow Nasal Cannula Market Value Share, by Component, 2017 and 2025
Figure 71: Middle East & Africa High-flow Nasal Cannula Market Attractiveness, by Component, 2017–2025
Figure 72: Middle East & Africa High-flow Nasal Cannula Market Value Share, by Application, 2017 and 2025
Figure 73: Middle East & Africa High-flow Nasal Cannula Market Attractiveness, by Application, 2017–2025
Figure 74: Middle East & Africa High-flow Nasal Cannula Market Value Share, by End-user, 2017 and 2025
Figure 75: Middle East & Africa High-flow Nasal Cannula Market Attractiveness, by End-user, 2017–2025
Figure 76: Global High-flow Nasal Cannula Market Share, by Company, 2016
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
High-flow Nasal Cannula Market
*86 figures and 60 tables includes